UBS Group AG - ONCOSEC MED INC ownership

ONCOSEC MED INC's ticker is ONCS and the CUSIP is 68234L306. A total of 27 filers reported holding ONCOSEC MED INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ONCOSEC MED INC
ValueSharesWeighting
Q1 2022$9,000
+28.6%
8,185
+219.2%
0.00%
Q2 2021$7,000
+40.0%
2,564
+142.1%
0.00%
Q1 2021$5,000
-73.7%
1,059
-63.6%
0.00%
Q4 2020$19,000
+5.6%
2,911
-46.2%
0.00%
Q3 2020$18,000
+80.0%
5,408
-32.5%
0.00%
Q1 2020$10,000
+400.0%
8,010
+765.9%
0.00%
Q4 2019$2,0000.0%925
-9.8%
0.00%
Q3 2019$2,0000.0%1,025
+13.9%
0.00%
Q2 2019$2,0009000.00%
Other shareholders
ONCOSEC MED INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sandbox Financial Partners, LLC 75,000$484,0000.44%
Avidity Partners Management LP 1,952,000$12,590,0000.41%
One68 Global Capital, LLC 22,261$144,0000.29%
J. Goldman & Co LP 521,820$3,366,0000.17%
SALZHAUER MICHAEL 27,303$176,0000.12%
683 Capital Management, LLC 124,191$801,0000.04%
D.A. DAVIDSON & CO. 118,000$761,0000.01%
Schonfeld Strategic Advisors LLC 106,226$685,0000.01%
Sigma Planning Corp 32,802$212,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 20,408$132,0000.01%
View complete list of ONCOSEC MED INC shareholders